Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Real-world observational experience with direct-acting antivirals for hepatitis C: baseline resistance, efficacy, and need for long-term surveillance.
Journal: Medicine
Published: July 03, 2019
Ombitasvir/paritaprevir/ritonavir + dasabuvir +/- ribavirin in real world hepatitis C patients.
Journal: World journal of gastroenterology
Published: February 03, 2019
Sofosbuvir-velpatasvir-voxilaprevir with or without ribavirin in direct-acting antiviral-experienced patients with genotype 1 hepatitis C virus.
Journal: Hepatology (Baltimore, Md.)
Published: January 24, 2017
Short-duration treatment with elbasvir/grazoprevir and sofosbuvir for hepatitis C: A randomized trial.
Journal: Hepatology (Baltimore, Md.)
Published: July 07, 2016
Dual therapy of grazoprevir and elbasvir for the treatment of hepatitis C infection.
Journal: Expert review of gastroenterology & hepatology
Published: January 29, 2016
Lorcaserin Use in the Management of Morbid Obesity in a Pre-Liver Transplant Patient.
Journal: Hepatology (Baltimore, Md.)
Published: December 19, 2015
Treatment of patients with hepatitis C virus genotype 3: Where are we now?
Journal: Clinical liver disease
Published: July 15, 2015
Prone positioning for transjugular intrahepatic portosystemic shunt revision to prevent exacerbation of existing radiation dermatitis.
Journal: Journal of vascular and interventional radiology : JVIR
Published: October 12, 2014
Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment.
Journal: Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition
Published: January 05, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026